About US
Contact us
-
Pfizer weighing a $2B women's health sale, report says. Will it fare better than Allergan?Earlier this year, Pfizer struck out on a sale of its consumer health unit. But it may be ready to try its hand at another selloff. The New York drugmaker is weighing options for its women’s health l2018/11/5
-
Novo Nordisk expands job cuts to 1,300 as executives play down Lilly’s GLP-1 threatDiabetes giant Novo Nordisk has been slimming down this year, and now we know just how much. First it was 400 R&D jobs, then about 250 positions in the U.S., and now the company says it will have2018/11/5
-
Novo Nordisk leads pharma pack breaking into Reputation Institute’s corporate responsibility rankingBig pharma’s reputation may be on the upswing, at least when it comes to corporate responsibility. Last year only Johnson & Johnson cracked the top 100 in Reputation Institute’s annual measurement2018/10/31
-
Pfizer manufacturing ills mean ongoing shortages for hospitalsPfizer acknowledged Tuesday that it continues to struggle with manufacturing at some Hospira plants, an issue that bodes ill not just for investors but also for U.S. hospitals. The manufacturing probl2018/10/31
-
Abbott and AbbVie settle TriCor marketing caseAmerican healthcare company Abbott Laboratories and AbbVie have reached a $25m settlement with US authorities to resolve charges that they paid kickbacks to doctors to encourage them to prescribechole2018/10/30
-
JW Pharmaceutical invests in British anti-cancer drugs developerSouth Korea-based pharmaceutical products company JW Pharmaceutical has invested $2.6m in British anti-cancer drugs developer Argonaut Therapeutics. This investment gives JW Pharmaceutical a 25% shar2018/10/30
-
Pfizer works to get 'wait-and-see' doctors on board the Ibrance trainMUNICH—Evidence in favor of the relatively new CDK 4/6 class of breast cancer drugs, which stars Pfizer’s Ibrance, continues to pile up—but it hasn’t yet been enough to convince some doctors to give t2018/10/29
-
Opdivo will keep growing, Bristol-Myers says, trying to talk investors off the ledgeIt’s no secret that Bristol-Myers Squibb’s investors are feeling skittish after a pair of negative Opdivo developments last week. And on Thursday’s third-quarter conference call, executives plunged ri2018/10/29
-
UK crackdown yields £2m of counterfeit medicinesThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has seized more than one million doses of fake medicines with a combined worth of nearly £2m. The crackdown on counterfeit medi2018/10/26
-
Trump signs bipartisan opioid bill into law to tackle rising US crisisUS President Donald Trump has signed a bipartisan opioid bill into law called SUPPORT for Patients and Communities Act to combat a growing substance crisis in the country. According to areport by the2018/10/26